Morris, Don G
$852,300.00
Canadian Institutes of Health Research | Instituts de recherche en santé du Canada
FY 2018-2019
Canada
MGMT promoter methylated breast cancer: An opportunity for a targeted treatment with alkylating agent temozolomide in combination with existing breast cancer therapeutics.